Characterizing real world safety profile of oral Janus kinase inhibitors among adult atopic dermatitis patients: evidence transporting from the rheumatoid arthritis population

References

• Chiesa Fuxench ZC, Block JK, Boguniewicz M, et al. Atopic dermatitis in America study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population. J Invest Dermatol. 2019;139(3):583–590.
   PubMed Web of Science ®Google Scholar
• Wei W, Ghorayeb E, Andria ML, et al. A real-world study evaluating adeQUacy of existing systemic treatments for patients with moderate-to-severe atopic dermatitis (AD-QUEST): baseline treatment patterns and unmet needs assessment. J Invest Dermatol. 2017;137(5):S35.
   Web of Science ®Google Scholar
• Aletaha D, Smolen JS. The rheumatoid arthritis patient in the clinic: comparing more than 1300 consecutive DMARD courses. Rheumatology. 2002;41(12):1367–1374.
   PubMed Web of Science ®Google Scholar
• Harrington R, Al Nokhatha SA, Conway R. JAK inhibitors in rheumatoid arthritis: an evidence-based review on the emerging clinical data. J Inflamm Res. 2020;13:519–531.
   PubMed Web of Science ®Google Scholar
• AbbVie. European Commission Approves RINVOQ (upadacitinib) as First JAK inhibitor in the European Union for the treatment of both adults and adolescents with moderate to severe atopic dermatitis [Internet]; 2021 [cited 2021 Aug 24]. Available from: https://www.prnewswire.com/news-releases/european-commission-approves-rinvoq-upadacitinib-as-first-jak-inhibitor-in-the-european-union-for-the-treatment-of-both-adults-and-adolescents-with-moderate-to-severe-atopic-dermatitis-301361058.html.
   Google Scholar
• Eichenfield LF, Flohr C, Sidbury R, et al. Efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis: the JADE TEEN randomized clinical trial. JAMA Dermatol. 2021;157(10):1165–1173.
   PubMed Web of Science ®Google Scholar
• Guttman-Yassky E, Teixeira HD, Simpson EL, et al. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (measure up 1 and measure up 2): results from two replicate double-blind, randomised controlled phase 3 trials. Lancet. 2021;397(10290):2151–2168.
   PubMed Web of Science ®Google Scholar
• Reich K, Teixeira HD, de Bruin-Weller M, et al. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD up): results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2021;397(10290):2169–2181.
   PubMed Web of Science ®Google Scholar
• Silverberg JI, Simpson EL, Thyssen JP, et al. Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2020;156(8):863–873.
   PubMed Web of Science ®Google Scholar
• Optum. Optum’s de-identifed clinformatics data mart database [Internet]; 2007–2019. Available from: https://www.optum.com/content/dam/optum/resources/productSheets/Clinformatics_for_Data_Mart.pdf.
   Google Scholar
• Brunner PM, Silverberg JI, Guttman-Yassky E, Councilors of the International Eczema Council, et al. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol. 2017;137(1):18–25.
   PubMed Web of Science ®Google Scholar
• Dharmage SC, Lowe AJ, Matheson MC, et al. Atopic dermatitis and the atopic march revisited. Allergy. 2014;69(1):17–27.
   PubMed Web of Science ®Google Scholar
• Čelakovská J, Bukač J, Va\vnková R, et al. Sensitisation to molecular components in patients with atopic dermatitis, relation to asthma bronchiale and allergic rhinitis. Food Agric Immunol. 2020;31(1):600–629.
   Web of Science ®Google Scholar
• Rector TS, Wickstrom SL, Shah M, et al. Specificity and sensitivity of claims-based algorithms for identifying members of Medicare + Choice health plans that have chronic medical conditions. Health Serv Res. 2004;39(6 Pt 1):1839–1858.
   PubMed Web of Science ®Google Scholar
• Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083–3107.
   PubMed Web of Science ®Google Scholar
• Westreich D, Edwards JK, Lesko CR, et al. Transportability of trial results using inverse odds of sampling weights. Am J Epidemiol. 2017;186(8):1010–1014.
   PubMed Web of Science ®Google Scholar
• Westreich D, Edwards JK, Lesko CR, et al. Target validity and the hierarchy of study designs. Am J Epidemiol. 2019;188(2):438–443.
   PubMed Web of Science ®Google Scholar
• Tipton E. How generalizable is your experiment? An index for comparing experimental samples and populations. J Educ Behav Stat. 2014;39(6):478–501.
   Web of Science ®Google Scholar
• Ackerman B, Schmid I, Rudolph KE, et al. Implementing statistical methods for generalizing randomized trial findings to a target population. Addict Behav. 2019;94:124–132.
   PubMed Web of Science ®Google Scholar
• Van Buuren S, Brand JPL, Groothuis-Oudshoorn CGM, et al. Fully conditional specification in multivariate imputation. J Stat Comput Simul. 2006;76(12):1049–1064.
   Web of Science ®Google Scholar
• Ling A, Montez-Rath M, Mathur M, et al. How to apply multiple imputation in propensity score matching with partially observed confounders: a simulation study and practical recommendations. J Mod Appl Stat Methods. 2020;19:eP3439.
   Web of Science ®Google Scholar
• Little RJA, Rubin DB. Statistical analysis with missing data. Hoboken (NJ): Wiley; 2019.
   Google Scholar
• R Core Team. R: a language and environment for statistical computing [Internet]. Vienna, Austria; 2018. Available from: https://www.r-project.org/.
   Google Scholar
• van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1–67.
   Web of Science ®Google Scholar
• Højsgaard S, Halekoh U, Yan J. The R package geepack for generalized estimating equations. J Stat Softw. 2005;15:1–11.
   Web of Science ®Google Scholar
• Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):3–14.
   PubMed Web of Science ®Google Scholar
• Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004;117(1):19–25.
   PubMed Web of Science ®Google Scholar
• Lopman BA, Hall AJ, Curns AT, et al. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin Infect Dis. 2011;52(4):466–474.
   PubMed Web of Science ®Google Scholar
• Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States—major pathogens. Emerg Infect Dis. 2011;17(1):7–15.
   PubMed Web of Science ®Google Scholar
• Grytdal SP, Rimland D, Shirley SH, et al. Incidence of medically-attended norovirus-associated acute gastroenteritis in four Veteran's Affairs Medical Center Populations in the United States, 2011–2012. PLOS One. 2015;10(5):e0126733.
   PubMed Web of Science ®Google Scholar
• Cole SR, Stuart EA. Generalizing evidence from randomized clinical trials to target populations: the ACTG 320 trial. Am J Epidemiol. 2010;172(1):107–115.
   PubMed Web of Science ®Google Scholar
• Desai RJ, Pawar A, Weinblatt ME, et al. Comparative risk of venous thromboembolism in rheumatoid arthritis patients receiving tofacitinib versus those receiving tumor necrosis factor inhibitors: an observational cohort study. Arthritis Rheumatol. 2019;71(6):892–900.
   PubMed Web of Science ®Google Scholar
• Pappas DA, St John G, Etzel CJ, et al. Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study. Ann Rheum Dis. 2021;80(1):96–102.
   PubMed Web of Science ®Google Scholar
• Melo A, Carrascosa JM, Torres T. Baricitinib for the treatment of atopic dermatitis. J Dermatolog Treat. 2021;1–30. DOI:https://doi.org/10.1080/09546634.2021.1967268
   Web of Science ®Google Scholar